MiniMed Group, Inc. MMED recently announced results from a new randomized crossover study showing that glycemic outcomes remained nearly identical when patients used its MiniMed 780G automated insulin ...
New analyses examine Afrezza across pediatric A1c and efficacy, patient treatment satisfaction, use with AID algorithms and ...
Twenty-four adult participants with type 1 diabetes were randomized to use either the Simplera Sync™ or Instinct sensor for a six-week period, then crossed over to the alternate sensor for an ...
Ralinepag works by restoring prostacyclin signaling and activating prostacyclin receptors to affect pathways that play a role in the progression of PAH. The drug was originally formulated as an ...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced the clinical launch of the ...
Gambling has evolved far beyond casinos and betting shops. Modern gambling systems now rely on digital mechanics built around ...
Read more about Age-friendly healthcare needs better digital design as older adults face usability gaps on Devdiscourse ...
Morning Overview on MSN
Hospitals are now letting AI read mammograms first — and a major study found it caught 20% more cancers than doctors working alone
When a woman walks into a breast cancer screening clinic in Sweden or Germany today, her mammogram may be scored by an ...
The Orthopaedic Research and Education Foundation (OREF) awarded the 2026 Career Development Grant, its most prestigious award, to Alvin Su, MD, PhD, of Nemours Children's Hospital, Delaware, and ...
Clinical trial teams are under increasing pressure to manage complex protocols, fragmented systems and rising operational demands while maintaining data quality, compliance and study timelines. This ...
Secret Life of Mom on MSN
Scientists finally debunked seed oil myths: Here's what they found
Seed oils line most kitchen cabinets. They also, apparently, line the road to chronic disease – at least according to a ...
The Vigilant AI Monitoring Operations System (VAMOS) was developed at Vanderbilt to monitor AI performance in real-time; now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results